drugset / Trial / NCT03709758
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
Phase 1
Active not recruiting
50 enrolled
Dana-Farber Cancer Institute
AbbVie · collabGenentech, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying the combination of venetoclax and chemotherapy as a possible treatment for acute myelogenous leukemia (AML). The drugs involved in this study are: * Venetoclax * Daunorubicin * Cytarabine
Timeline
- Start
- 2018-10-17
- Primary completion
- 2025-02-23
- Completion
- 2026-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venetoclax | Small molecule | — | Oral |
| Background | Cytarabine | Small molecule | — | Intravenous |
| Background | Daunorubicin | Small molecule | — | Intravenous |